Omeros Corporation (OMER) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $11.55
• Market Cap: $806.85M
• EPS: $-1.99
• 52-Week High: $17.65
• 52-Week Low: $2.95

Market Sentiment

Omeros Corporation currently has a Bullish sentiment score of 0.47.

About Omeros Corporation

Omeros Corporation is a Seattle-based biopharmaceutical firm that specializes in the discovery, development, and commercialization of novel therapeutics aimed at serious conditions. The company boasts a diverse pipeline featuring both protein and small molecule therapies, targeting critical unmet medical needs in areas such as inflammation, complement-mediated diseases, and central nervous system (CNS) disorders. With a strategic focus on orphan indications, Omeros is well-equipped to drive g...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Omeros Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does OMER pay dividends?

Omeros Corporation (OMER) does not currently pay a regular dividend.

What is OMER's market cap?

Omeros Corporation (OMER) has a market capitalization of $806.85M with a current stock price of $11.55.